Hims & Hers Health, Inc. (HIMS) Isn’t Regarded As A Great Actor By Doctors, Says Jim Cramer

We have recently published 14 stocks. Jim Kramer discussed the price of bitcoin record. Hims & HERS Health, Inc. (NYSE: HIMS) is one of the arrows that Jim Cramer recently discussed.

Hims & HERS Health, Inc. (NYSE: HIMS) is a well -known digital health platform that allows users to order medicines after securing medical prescriptions. Despite the multiple opposite winds in 2025, stocks still rise by 93 % of the year. The shares of Hims & HERS Health, Inc. Then, after the stock gained 61 % by late June, it was destroyed again and lost 35 %. This time, Hims & HERS Health, Inc. (NYSE: HIMS) where the Novo Nordisk is finished with its partnership with the company. As for Cramer, he commented on the company’s business:

By the way, when you talk to doctors, you are talking to people at work, and Hims & Hers is a representative not great. I think they are a good representative of people. “

Earlier, CNBC host discussed the seller’s open feelings for Hims & HERS Health, Inc. (NYSE: HIMS):

“Regardless of the love of these speculative winners, you will not have a gain until you actually ring the record. At the end of last week, for example, Hims & HERS Health, online health care company, was traded at $ 64. But yesterday, the stock decreased $ 22 against approximately 35 % … What this shares are interested in … [has] It doubles almost three times in two months. If you have Hims & salary for nearly 200 % and you haven’t sold anything at that point, you were detailed.

A nurse on the health care platform remotely talks to a patient on a video call for consultation.

Why? Because this is one of the most deficient stocks in the market. 35 % of short shares have been sold. Many people were betting on that. The haters are abundant. In this case, the arrow can erupt in any good news. There was a lot of good news when HIMS earned money with the Wegov deal.

While we recognize its capabilities as an investment, our conviction lies in the belief that some of the artificial intelligence shares have a greater promise to provide higher and limited returns than negative risks. If you are looking for a very cheap inventory of artificial intelligence and is also a major beneficiary of the Trump and Bundge tariff, see our free report on The best inventory of artificial intelligence in the short term.